Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial ASCO convened an Expert Panel and updated the systematic review to ...
Our guidelines are based on the best available evidence. Our recommendations are put together by experts, people using services, carers and the public. We review the evidence relevant to the guideline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results